However, beneath this success lies a growing concern: the sustainability of this growth trajectory, particularly as ...

Bristol Myers Squibb is partnering with BioNTech on a closely watched cancer drug, in a deal worth billions of dollars.

Drugs that boost the body’s immune system to fight disease are showing promise in treating a variety of cancers in earlier ...